Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Packer

Showing results (471-480 of 706) with videos related to

Pageof 71
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 1, 1989
Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumorsW M Molenaar, D S Jansson, V E Gould, et al.
Cancer|April 11, 2016
Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology GroupJoann L Ater, Caihong Xia, Claire M Mazewski, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1990
Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteinsV E Gould, D S Jansson, W M Molenaar, et al.
Oncotarget|December 29, 2016
Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumorElizabeth Wells, Madhuri Kambhampati, Jesse M Damsker, et al.
Pediatric Blood & Cancer|February 24, 2015
Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology GroupRegina I Jakacki, Peter C Burger, Mehmet Kocak, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance ImagingZhifan Jiang, Abhijeet Parida, Syed Muhammad Anwar, et al.
Human Pathology|March 1, 1990
Primitive neuroectodermal tumors of the central nervous system express neuroendocrine markers and may express all classes of intermediate filamentsV E Gould, L B Rorke, D S Jansson, et al.
Pediatric Neurology|April 12, 2012
Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformationsMaria T Acosta, Karin S Walsh, Peter G Kardel, et al.
Pediatric Neurosurgery|June 10, 1998
Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumorsE D Kramer, R J Packer, J Ginsberg, et al.
Pediatric Neuroscience|January 1, 1987
Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossaR J Packer, R Sposto, T E Atkins, et al.
Pageof 71

Showing results (471-480 of 706) with videos related to

Sort By:
Pageof 71
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 1, 1989
Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumorsW M Molenaar, D S Jansson, V E Gould, et al.
Cancer|April 11, 2016
Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology GroupJoann L Ater, Caihong Xia, Claire M Mazewski, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1990
Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteinsV E Gould, D S Jansson, W M Molenaar, et al.
Oncotarget|December 29, 2016
Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumorElizabeth Wells, Madhuri Kambhampati, Jesse M Damsker, et al.
Pediatric Blood & Cancer|February 24, 2015
Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology GroupRegina I Jakacki, Peter C Burger, Mehmet Kocak, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance ImagingZhifan Jiang, Abhijeet Parida, Syed Muhammad Anwar, et al.
Human Pathology|March 1, 1990
Primitive neuroectodermal tumors of the central nervous system express neuroendocrine markers and may express all classes of intermediate filamentsV E Gould, L B Rorke, D S Jansson, et al.
Pediatric Neurology|April 12, 2012
Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformationsMaria T Acosta, Karin S Walsh, Peter G Kardel, et al.
Pediatric Neurosurgery|June 10, 1998
Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumorsE D Kramer, R J Packer, J Ginsberg, et al.
Pediatric Neuroscience|January 1, 1987
Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossaR J Packer, R Sposto, T E Atkins, et al.
Pageof 71